25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BNGO (Bionano) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bionano together

I guess you are interested in Bionano Genomics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Bionano’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Bionano’s Price Targets

I'm going to help you getting a better view of Bionano Genomics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bionano Genomics Inc

I send you an email if I find something interesting about Bionano Genomics Inc.

1. Quick Overview

1.1. Quick analysis of Bionano (30 sec.)










1.2. What can you expect buying and holding a share of Bionano? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$11.76
Expected worth in 1 year
$21.43
How sure are you?
24.2%

+ What do you gain per year?

Total Gains per Share
$9.66
Return On Investment
266.9%

For what price can you sell your share?

Current Price per Share
$3.62
Expected price per share
$2.68 - $5.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bionano (5 min.)




Live pricePrice per Share (EOD)
$3.62
Intrinsic Value Per Share
$-85.36 - $-101.19
Total Value Per Share
$-73.60 - $-89.43

2.2. Growth of Bionano (5 min.)




Is Bionano growing?

Current yearPrevious yearGrowGrow %
How rich?$35.3m$165.3m-$103.5m-167.4%

How much money is Bionano making?

Current yearPrevious yearGrowGrow %
Making money-$28m-$58.1m$30.1m107.6%
Net Profit Margin-385.6%-641.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Bionano (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bionano?

Welcome investor! Bionano's management wants to use your money to grow the business. In return you get a share of Bionano.

First you should know what it really means to hold a share of Bionano. And how you can make/lose money.

Speculation

The Price per Share of Bionano is $3.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionano.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionano, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $11.76. Based on the TTM, the Book Value Change Per Share is $2.42 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionano.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-6.69-184.9%-2.01-55.6%-1.66-45.7%-1.60-44.3%-1.38-38.2%-1.72-47.4%
Usd Book Value Change Per Share11.20309.3%2.4266.7%-1.57-43.4%-0.01-0.2%0.5314.6%0.369.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share11.20309.3%2.4266.7%-1.57-43.4%-0.01-0.2%0.5314.6%0.369.8%
Usd Price Per Share0.29-0.63-1.66-1.37-2.25-2.03-
Price to Earnings Ratio-0.01--0.35--0.27--0.34--0.80--0.57-
Price-to-Total Gains Ratio0.03--1.14--1.12--1.81--2.96--2.54-
Price to Book Ratio0.02-0.52-0.51-0.41-0.43-0.28-
Price-to-Total Gains Ratio0.03--1.14--1.12--1.81--2.96--2.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.62
Number of shares276
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.420.53
Usd Total Gains Per Share2.420.53
Gains per Quarter (276 shares)666.71145.97
Gains per Year (276 shares)2,666.85583.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10266726570584574
2053345324011681158
3080017991017521742
401066710658023362326
501333413325029192910
601600115992035033494
701866818659040874078
802133521326046714662
902400223993052555246
1002666926660058395830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.032.00.03.0%1.032.00.03.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%5.015.00.025.0%8.024.01.024.2%8.024.01.024.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.033.00.0%0.00.033.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%5.015.00.025.0%8.024.01.024.2%8.024.01.024.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bionano Genomics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--11.1952.416+363%-1.573+114%-0.009+100%0.529+2017%0.356+3040%
Book Value Per Share--11.7643.773+212%4.966+137%6.165+91%6.406+84%2.666+341%
Current Ratio--1.0571.394-24%2.850-63%4.051-74%8.616-88%6.000-82%
Debt To Asset Ratio--0.5390.459+17%0.328+64%0.307+75%0.350+54%0.943-43%
Debt To Equity Ratio--1.1670.869+34%0.571+104%0.532+119%0.643+82%0.810+44%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---30952781.20011075293.950-379%71422695.000-143%88542417.567-135%146611140.812-121%113983608.367-127%
Eps---6.693-2.011-70%-1.655-75%-1.604-76%-1.381-79%-1.715-74%
Ev To Ebitda Ratio--0.438-0.081+118%-0.383+187%-0.675+254%-2.007+558%-1.612+468%
Ev To Sales Ratio---0.9480.388-344%1.994-148%3.114-130%7.585-112%5.946-116%
Free Cash Flow Per Share---2.163-0.791-63%-0.942-56%-0.947-56%-0.930-57%-1.500-31%
Free Cash Flow To Equity Per Share---0.869-0.560-36%-0.190-78%-0.553-36%0.226-485%0.267-425%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---101.191----------
Intrinsic Value_10Y_min---85.364----------
Intrinsic Value_1Y_max---4.712----------
Intrinsic Value_1Y_min---4.626----------
Intrinsic Value_3Y_max---18.295----------
Intrinsic Value_3Y_min---17.383----------
Intrinsic Value_5Y_max---36.865----------
Intrinsic Value_5Y_min---33.862----------
Market Cap10885340.000+92%867218.80036051293.950-98%61447945.000-99%49936417.567-98%65146722.912-99%41485059.652-98%
Net Profit Margin---2.465-3.856+56%-6.418+160%-5.024+104%-5.017+103%-4.012+63%
Operating Margin---2.462-2.015-18%-6.295+156%-4.351+77%-4.567+86%-3.688+50%
Operating Ratio--2.4634.494-45%4.840-49%5.035-51%5.378-54%4.612-47%
Pb Ratio0.308+92%0.0250.525-95%0.507-95%0.405-94%0.433-94%0.282-91%
Pe Ratio-0.135-1155%-0.011-0.351+3155%-0.270+2408%-0.342+3072%-0.801+7339%-0.567+5165%
Price Per Share3.620+92%0.2880.633-54%1.660-83%1.368-79%2.251-87%2.030-86%
Price To Free Cash Flow Ratio-0.418-1155%-0.033-0.457+1272%-0.503+1408%-0.456+1269%-0.878+2535%-0.620+1759%
Price To Total Gains Ratio0.323+92%0.026-1.143+4538%-1.123+4459%-1.815+7145%-2.959+11586%-2.540+9962%
Quick Ratio--0.3901.065-63%3.401-89%5.763-93%10.470-96%6.988-94%
Return On Assets---0.262-0.273+4%-0.273+4%-0.216-18%-0.205-22%-0.277+5%
Return On Equity---0.569-0.514-10%-0.436-23%-0.356-37%-0.347-39%-0.346-39%
Total Gains Per Share--11.1952.416+363%-1.573+114%-0.009+100%0.529+2017%0.356+3040%
Usd Book Value--35375000.00061837750.000-43%165349750.000-79%169650750.000-79%173722908.700-80%100959172.636-65%
Usd Book Value Change Per Share--11.1952.416+363%-1.573+114%-0.009+100%0.529+2017%0.356+3040%
Usd Book Value Per Share--11.7643.773+212%4.966+137%6.165+91%6.406+84%2.666+341%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---30952781.20011075293.950-379%71422695.000-143%88542417.567-135%146611140.812-121%113983608.367-127%
Usd Eps---6.693-2.011-70%-1.655-75%-1.604-76%-1.381-79%-1.715-74%
Usd Free Cash Flow---6504000.000-17256250.000+165%-32848250.000+405%-27378000.000+321%-21779047.300+235%-16125129.424+148%
Usd Free Cash Flow Per Share---2.163-0.791-63%-0.942-56%-0.947-56%-0.930-57%-1.500-31%
Usd Free Cash Flow To Equity Per Share---0.869-0.560-36%-0.190-78%-0.553-36%0.226-485%0.267-425%
Usd Market Cap10885340.000+92%867218.80036051293.950-98%61447945.000-99%49936417.567-98%65146722.912-99%41485059.652-98%
Usd Price Per Share3.620+92%0.2880.633-54%1.660-83%1.368-79%2.251-87%2.030-86%
Usd Profit---20125000.000-28004250.000+39%-58123250.000+189%-39758833.333+98%-29532378.050+47%-20641606.152+3%
Usd Revenue--8163000.0007694000.000+6%9029000.000-10%7891166.667+3%6058931.300+35%4836573.091+69%
Usd Total Gains Per Share--11.1952.416+363%-1.573+114%-0.009+100%0.529+2017%0.356+3040%
 EOD+6 -2MRQTTM+16 -21YOY+16 -213Y+16 -215Y+16 -2210Y+18 -20

3.3 Fundamental Score

Let's check the fundamental score of Bionano Genomics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.135
Price to Book Ratio (EOD)Between0-10.308
Net Profit Margin (MRQ)Greater than0-2.465
Operating Margin (MRQ)Greater than0-2.462
Quick Ratio (MRQ)Greater than10.390
Current Ratio (MRQ)Greater than11.057
Debt to Asset Ratio (MRQ)Less than10.539
Debt to Equity Ratio (MRQ)Less than11.167
Return on Equity (MRQ)Greater than0.15-0.569
Return on Assets (MRQ)Greater than0.05-0.262
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.550
Ma 20Greater thanMa 503.928
Ma 50Greater thanMa 1003.690
Ma 100Greater thanMa 2005.917
OpenGreater thanClose3.740
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Bionano Genomics Inc

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2025-05-06 07:41:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Bionano earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -246.5%Β means thatΒ $-2.47 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionano Genomics Inc:

  • The MRQ is -246.5%. The company is making a huge loss. -2
  • The TTM is -385.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-246.5%TTM-385.6%+139.0%
TTM-385.6%YOY-641.8%+256.3%
TTM-385.6%5Y-501.7%+116.1%
5Y-501.7%10Y-401.2%-100.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-246.5%5.0%-251.5%
TTM-385.6%4.5%-390.1%
YOY-641.8%6.1%-647.9%
3Y-502.4%6.8%-509.2%
5Y-501.7%6.9%-508.6%
10Y-401.2%6.5%-407.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Bionano is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • -26.2% Return on Assets means thatΒ Bionano generatedΒ $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionano Genomics Inc:

  • The MRQ is -26.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.2%TTM-27.3%+1.1%
TTM-27.3%YOY-27.3%+0.0%
TTM-27.3%5Y-20.5%-6.9%
5Y-20.5%10Y-27.7%+7.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.2%0.9%-27.1%
TTM-27.3%0.8%-28.1%
YOY-27.3%1.0%-28.3%
3Y-21.6%1.2%-22.8%
5Y-20.5%1.5%-22.0%
10Y-27.7%1.5%-29.2%
4.3.1.3. Return on Equity

Shows how efficient Bionano is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • -56.9% Return on Equity means Bionano generated $-0.57Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionano Genomics Inc:

  • The MRQ is -56.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -51.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-56.9%TTM-51.4%-5.5%
TTM-51.4%YOY-43.6%-7.8%
TTM-51.4%5Y-34.7%-16.7%
5Y-34.7%10Y-34.6%-0.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.9%2.2%-59.1%
TTM-51.4%1.7%-53.1%
YOY-43.6%2.1%-45.7%
3Y-35.6%2.5%-38.1%
5Y-34.7%3.1%-37.8%
10Y-34.6%2.8%-37.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bionano Genomics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Bionano is operatingΒ .

  • Measures how much profit Bionano makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • An Operating Margin of -246.2%Β means the company generated $-2.46 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionano Genomics Inc:

  • The MRQ is -246.2%. The company is operating very inefficient. -2
  • The TTM is -201.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-246.2%TTM-201.5%-44.7%
TTM-201.5%YOY-629.5%+428.0%
TTM-201.5%5Y-456.7%+255.2%
5Y-456.7%10Y-368.8%-88.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-246.2%7.1%-253.3%
TTM-201.5%7.3%-208.8%
YOY-629.5%6.3%-635.8%
3Y-435.1%6.5%-441.6%
5Y-456.7%8.6%-465.3%
10Y-368.8%8.5%-377.3%
4.3.2.2. Operating Ratio

Measures how efficient Bionano is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.46 means that the operating costs are $2.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionano Genomics Inc:

  • The MRQ is 2.463. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.494. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.463TTM4.494-2.031
TTM4.494YOY4.840-0.346
TTM4.4945Y5.378-0.884
5Y5.37810Y4.612+0.765
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4631.114+1.349
TTM4.4941.104+3.390
YOY4.8401.015+3.825
3Y5.0351.053+3.982
5Y5.3781.048+4.330
10Y4.6120.991+3.621
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bionano Genomics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bionano is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.06Β means the company has $1.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.057. The company is just able to pay all its short-term debts.
  • The TTM is 1.394. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.057TTM1.394-0.337
TTM1.394YOY2.850-1.456
TTM1.3945Y8.616-7.223
5Y8.61610Y6.000+2.617
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0572.071-1.014
TTM1.3942.046-0.652
YOY2.8502.458+0.392
3Y4.0512.511+1.540
5Y8.6162.689+5.927
10Y6.0002.612+3.388
4.4.3.2. Quick Ratio

Measures if Bionano is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.39Β means the company can pay off $0.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionano Genomics Inc:

  • The MRQ is 0.390. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.065. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.390TTM1.065-0.676
TTM1.065YOY3.401-2.335
TTM1.0655Y10.470-9.405
5Y10.47010Y6.988+3.482
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3900.917-0.527
TTM1.0651.014+0.051
YOY3.4011.161+2.240
3Y5.7631.310+4.453
5Y10.4701.498+8.972
10Y6.9881.643+5.345
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bionano Genomics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BionanoΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Bionano to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.54Β means that Bionano assets areΒ financed with 53.9% credit (debt) and the remaining percentage (100% - 53.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Bionano Genomics Inc:

  • The MRQ is 0.539. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.459. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.539TTM0.459+0.080
TTM0.459YOY0.328+0.130
TTM0.4595Y0.350+0.108
5Y0.35010Y0.943-0.593
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5390.394+0.145
TTM0.4590.382+0.077
YOY0.3280.344-0.016
3Y0.3070.349-0.042
5Y0.3500.357-0.007
10Y0.9430.374+0.569
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Bionano is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 116.7% means that company has $1.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.167. The company is able to pay all its debts with equity. +1
  • The TTM is 0.869. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.167TTM0.869+0.299
TTM0.869YOY0.571+0.298
TTM0.8695Y0.643+0.226
5Y0.64310Y0.810-0.167
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1670.615+0.552
TTM0.8690.604+0.265
YOY0.5710.552+0.019
3Y0.5320.578-0.046
5Y0.6430.567+0.076
10Y0.8100.665+0.145
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Bionano generates.

  • Above 15 is considered overpriced butΒ always compareΒ Bionano to theΒ Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.01 means the investor is paying $-0.01Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.135. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.011. Based on the earnings, the company is expensive. -2
  • The TTM is -0.351. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.135MRQ-0.011-0.124
MRQ-0.011TTM-0.351+0.340
TTM-0.351YOY-0.270-0.080
TTM-0.3515Y-0.801+0.451
5Y-0.80110Y-0.567-0.234
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.13514.762-14.897
MRQ-0.01114.911-14.922
TTM-0.35114.987-15.338
YOY-0.27017.819-18.089
3Y-0.34218.703-19.045
5Y-0.80120.461-21.262
10Y-0.56722.115-22.682
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.418. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.033. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.457. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.418MRQ-0.033-0.385
MRQ-0.033TTM-0.457+0.424
TTM-0.457YOY-0.503+0.045
TTM-0.4575Y-0.878+0.421
5Y-0.87810Y-0.620-0.259
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4189.150-9.568
MRQ-0.0339.166-9.199
TTM-0.4579.882-10.339
YOY-0.5034.673-5.176
3Y-0.4560.290-0.746
5Y-0.8782.348-3.226
10Y-0.620-1.934+1.314
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Bionano is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.02 means the investor is paying $0.02Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionano Genomics Inc:

  • The EOD is 0.308. Based on the equity, the company is cheap. +2
  • The MRQ is 0.025. Based on the equity, the company is cheap. +2
  • The TTM is 0.525. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.308MRQ0.025+0.283
MRQ0.025TTM0.525-0.500
TTM0.525YOY0.507+0.018
TTM0.5255Y0.433+0.092
5Y0.43310Y0.282+0.151
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.3082.440-2.132
MRQ0.0252.494-2.469
TTM0.5252.779-2.254
YOY0.5072.676-2.169
3Y0.4052.858-2.453
5Y0.4333.649-3.216
10Y0.2824.167-3.885
4.6.2. Total Gains per Share

2.4. Latest News of Bionano Genomics Inc

Does Bionano Genomics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Bionano Genomics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-05-14
22:01
Bionano Reports First Quarter 2025 Results and Highlights Recent Business ProgressRead
2025-05-07
22:01
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionano Genomics Inc.

4.8.1. Institutions holding Bionano Genomics Inc

Institutions are holding 8.898% of the shares of Bionano Genomics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31T. Rowe Price Associates, Inc.0.050307037000
2024-12-31SBI Securities Co Ltd0.00650.0001914991490
2024-12-31AllSquare Wealth Management LLC0.0001020000
2024-12-31Activest Wealth Management0.0001020000
2025-03-31GPS Wealth Strategies Group, LLC0.0007016-1-5.8824
2025-03-31Fifth Third Bancorp00100
2025-03-31Archford Capital Strategies, LLC000-1159-100
2025-03-31Modus Advisors000-2-100
2024-12-31State Street Corp000-113988-100
2024-12-31Hanson Mcclain Inc000-400-100
2024-12-31Abound Wealth Management000-150-100
2025-03-31Carret & Company Inc000-1983-100
2024-12-31Northern Trust Investments N A000-35578-100
2025-03-31Sunbelt Securities00000
2024-12-31JustInvest LLC000-13526-100
2024-12-31Compagnie Lombard, Odier SCA000-20-100
2024-12-31Citadel Advisors Llc000-249070-100
2024-12-31GMT Capital Corp000-530260-100
2024-12-31JONES FINANCIAL COMPANIES LLLP000-180-100
2024-12-31GSA Capital Partners LLP000-100414-100
Total 0.05770.000179936-1037582-1,298.0%

4.9.2. Funds holding Bionano Genomics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Total Stock Mkt Idx Inv1.7759041386-12227-22.806
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.0120.000216739167390
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.0120.000216739167390
2025-03-31Fidelity Extended Market Index0.42440.00019890-10829-52.266
2025-03-31Vanguard Institutional Extnd Mkt Idx Tr0.36130842000
2025-03-31Extended Equity Market Fund K0.1370.0001319390.2827
2025-03-31Fidelity Total Market Index0.11880276900
2025-03-31Fidelity Series Total Market Index0.1022023821155.0728
2025-03-31T. Rowe Price U.S. Equities Tr0.05030117200
2025-03-31Northern Trust Extended Eq Market Idx0.05020117000
2025-03-31NT Ext Equity Mkt Idx Fd - L0.05020117000
2025-03-31PGIM Quantitative Solutions US Micro Cap0.030.02697007000
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.0292068000
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02270529-10-1.8553
2025-03-31Spartan Total Market Index Pool E0.0198046100
2025-03-31Extended Equity Market Fund M0.01720.0001400-14-3.3816
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0121028120.7168
2025-03-31State St US Extended Mkt Indx NL Cl C0.0088020400
2025-03-31Fidelity Nasdaq Composite Index0.0074017300
2025-03-31Vanguard U.S. Eq Idx Β£ Acc0.0074017300
Total 3.24890.0276108631+11224+10.3%

5.3. Insider Transactions

Insiders are holding 0.072% of the shares of Bionano Genomics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-13Hannah MamuszkaBUY109456
2023-05-16R. Erik HolmlinBUY25384
2023-05-12Christopher P StewartBUY83402
2022-08-15Yvonne LinneySELL332172
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Net Debt  34,882-7,71227,170-21,0336,1377,52213,659-15,897-2,238



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets76,670
Total Liabilities41,295
Total Stockholder Equity35,375
 As reported
Total Liabilities 41,295
Total Stockholder Equity+ 35,375
Total Assets = 76,670

Assets

Total Assets76,670
Total Current Assets39,489
Long-term Assets37,179
Total Current Assets
Cash And Cash Equivalents 9,173
Short-term Investments 302
Net Receivables 4,774
Inventory 11,121
Other Current Assets 13,905
Total Current Assets  (as reported)39,489
Total Current Assets  (calculated)39,275
+/- 214
Long-term Assets
Property Plant Equipment 24,322
Intangible Assets 9,703
Long-term Assets Other 3,154
Long-term Assets  (as reported)37,179
Long-term Assets  (calculated)37,179
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities37,344
Long-term Liabilities3,951
Total Stockholder Equity35,375
Total Current Liabilities
Short-term Debt 3,268
Accounts payable 6,962
Other Current Liabilities 25,257
Total Current Liabilities  (as reported)37,344
Total Current Liabilities  (calculated)35,487
+/- 1,857
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,667
Long-term Liabilities  (as reported)3,951
Long-term Liabilities  (calculated)3,667
+/- 284
Total Stockholder Equity
Retained Earnings -693,225
Accumulated Other Comprehensive Income 27
Other Stockholders Equity 728,573
Total Stockholder Equity (as reported)35,375
Total Stockholder Equity (calculated)35,375
+/-0
Other
Cash and Short Term Investments 9,475
Common Stock Shares Outstanding 1,865
Current Deferred Revenue1,128
Liabilities and Stockholders Equity 76,670
Net Debt -2,238
Net Invested Capital 35,375
Net Working Capital 2,145
Property Plant and Equipment Gross 51,184
Short Long Term Debt Total 6,935



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,788
0
0
0
10,145
16,462
18,094
30,670
24,802
29,551
25,211
19,207
30,208
19,102
27,204
41,396
60,450
384,861
356,809
359,657
377,100
348,211
321,552
323,698
307,502
292,151
271,381
181,904
214,404
157,995
129,364
87,362
76,670
76,67087,362129,364157,995214,404181,904271,381292,151307,502323,698321,552348,211377,100359,657356,809384,86160,45041,39627,20419,10230,20819,20725,21129,55124,80230,67018,09416,46210,14500014,788
   > Total Current Assets 
10,736
5,250
0
0
7,139
13,848
15,654
28,621
23,025
28,014
23,932
17,839
28,258
16,982
24,654
29,240
46,789
370,251
341,965
342,047
272,414
242,360
216,288
218,197
157,298
142,557
122,575
104,537
140,118
85,611
60,568
46,980
39,489
39,48946,98060,56885,611140,118104,537122,575142,557157,298218,197216,288242,360272,414342,047341,965370,25146,78929,24024,65416,98228,25817,83923,93228,01423,02528,62115,65413,8487,139005,25010,736
       Cash And Cash Equivalents 
5,250
-5,250
0
0
1,022
7,553
7,624
20,657
16,523
20,830
15,295
8,225
17,311
8,144
17,194
18,867
38,449
362,057
332,554
140,736
24,571
24,048
27,159
28,166
5,091
4,104
14,856
34,568
53,065
15,759
21,433
8,794
9,173
9,1738,79421,43315,75953,06534,56814,8564,1045,09128,16627,15924,04824,571140,736332,554362,05738,44918,86717,1948,14417,3118,22515,29520,83016,52320,6577,6247,5531,02200-5,2505,250
       Short-term Investments 
0
10,499
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,333
226,041
192,420
160,178
152,024
108,095
91,704
62,206
29,014
48,823
37,007
8,516
14,160
302
30214,1608,51637,00748,82329,01462,20691,704108,095152,024160,178192,420226,041185,3330000000000000000010,4990
       Net Receivables 
1,847
0
0
0
3,352
2,536
2,886
4,001
4,514
4,057
4,984
6,001
6,334
4,115
3,249
3,860
2,775
1,992
2,838
2,996
4,934
5,514
4,851
5,829
7,022
6,780
7,613
8,669
9,661
8,313
6,255
5,316
4,774
4,7745,3166,2558,3139,6618,6697,6136,7807,0225,8294,8515,5144,9342,9962,8381,9922,7753,8603,2494,1156,3346,0014,9844,0574,5144,0012,8862,5363,3520001,847
       Inventory 
1,797
0
0
0
1,694
2,014
1,973
2,615
1,069
1,406
3,022
2,595
3,444
3,611
3,290
4,593
3,316
3,036
4,890
9,020
12,387
16,268
20,591
25,046
29,761
33,113
32,453
26,429
22,893
19,587
19,475
14,323
11,121
11,12114,32319,47519,58722,89326,42932,45333,11329,76125,04620,59116,26812,3879,0204,8903,0363,3164,5933,2903,6113,4442,5953,0221,4061,0692,6151,9732,0141,6940001,797
       Other Current Assets 
1,842
0
0
0
1,072
1,745
3,170
1,348
920
1,721
466
695
1,169
2,224
1,842
1,920
2,250
6,332
3,366
7,924
5,065
8,220
7,018
14,264
7,385
6,856
5,447
5,857
5,677
4,945
15,897
4,387
13,905
13,9054,38715,8974,9455,6775,8575,4476,8567,38514,2647,0188,2205,0657,9243,3666,3322,2501,9201,8422,2241,1696954661,7219201,3483,1701,7451,0720001,842
   > Long-term Assets 
0
-5,250
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
12,156
13,660
14,610
14,844
17,610
104,686
105,851
105,264
105,501
150,204
149,592
148,806
77,367
74,286
72,384
68,796
40,382
37,179
37,17940,38268,79672,38474,28677,367148,806149,592150,204105,501105,264105,851104,68617,61014,84414,61013,66012,1562,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,00600-5,2500
       Property Plant Equipment 
4,052
0
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
3,635
4,910
5,806
6,084
8,554
20,935
23,375
24,164
25,648
28,958
29,769
30,566
30,991
32,481
33,602
32,486
26,179
24,322
24,32226,17932,48633,60232,48130,99130,56629,76928,95825,64824,16423,37520,9358,5546,0845,8064,9103,6352,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,0060004,052
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,941
7,173
7,173
7,173
7,173
56,160
56,254
56,254
56,466
77,289
77,289
77,281
0
0
0
0
0
0
00000077,28177,28977,28956,46656,25456,25456,1607,1737,1737,1737,1736,941000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,580
1,475
1,396
1,317
1,238
26,842
25,424
24,005
22,585
41,143
39,349
37,559
35,766
33,972
31,734
30,021
11,045
9,703
9,70311,04530,02131,73433,97235,76637,55939,34941,14322,58524,00525,42426,8421,2381,3171,3961,4751,580000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103
235
270
645
749
798
841
802
2,814
2
3,400
10,610
0
0
0
0
2
2000010,6103,40022,8148028417987496452702351030000000000000000
> Total Liabilities 
16,630
0
0
0
60,372
70,482
75,372
15,435
14,665
23,681
26,556
26,586
26,640
23,315
21,367
26,720
25,367
22,143
10,943
18,092
39,982
37,026
36,818
41,956
58,104
60,664
56,625
62,905
118,247
75,224
49,027
38,494
41,295
41,29538,49449,02775,224118,24762,90556,62560,66458,10441,95636,81837,02639,98218,09210,94322,14325,36726,72021,36723,31526,64026,58626,55623,68114,66515,43575,37270,48260,37200016,630
   > Total Current Liabilities 
9,364
0
0
0
16,652
26,854
22,427
5,515
4,523
4,714
7,541
7,437
26,305
23,188
19,508
24,782
8,944
7,169
10,730
17,702
21,840
18,659
27,908
33,500
35,884
38,135
33,499
40,194
100,028
58,506
37,175
32,950
37,344
37,34432,95037,17558,506100,02840,19433,49938,13535,88433,50027,90818,65921,84017,70210,7307,1698,94424,78219,50823,18826,3057,4377,5414,7144,5235,51522,42726,85416,6520009,364
       Short-term Debt 
587
6,633
0
0
6,730
20,011
14,330
0
0
0
800
953
20,085
16,969
13,938
14,239
562
14,866
0
0
3,532
2,026
4,098
4,144
5,090
2,517
4,586
4,924
72,238
31,539
21,764
17,172
3,268
3,26817,17221,76431,53972,2384,9244,5862,5175,0904,1444,0982,0263,5320014,86656214,23913,93816,96920,08595380000014,33020,0116,730006,633587
       Short Long Term Debt 
587
6,633
0
0
6,730
6,681
23,286
0
0
0
800
953
20,085
16,969
13,938
14,239
0
0
0
0
0
0
0
0
0
0
0
0
69,803
29,080
19,359
14,953
0
014,95319,35929,08069,80300000000000014,23913,93816,96920,08595380000023,2866,6816,730006,633587
       Accounts payable 
792
0
0
0
2,303
936
1,752
2,364
1,352
871
3,618
2,634
2,699
3,176
2,850
5,665
2,930
2,209
3,745
7,875
9,696
6,590
7,695
9,407
12,534
15,780
11,912
15,369
10,384
9,844
8,734
8,700
6,962
6,9628,7008,7349,84410,38415,36911,91215,78012,5349,4077,6956,5909,6967,8753,7452,2092,9305,6652,8503,1762,6992,6343,6188711,3522,3641,7529362,303000792
       Other Current Liabilities 
7,985
0
0
0
7,408
5,741
6,104
2,815
2,900
3,629
2,702
3,432
2,957
2,725
2,431
4,466
5,037
4,659
6,540
9,416
7,935
8,251
15,393
19,186
17,435
17,846
16,104
19,177
15,507
15,037
4,465
6,070
25,257
25,2576,0704,46515,03715,50719,17716,10417,84617,43519,18615,3938,2517,9359,4166,5404,6595,0374,4662,4312,7252,9573,4322,7023,6292,9002,8156,1045,7417,4080007,985
   > Long-term Liabilities 
0
0
0
0
43,720
43,628
52,945
9,920
10,142
18,968
19,015
19,149
335
127
1,859
1,938
16,423
14,974
213
390
18,142
18,367
8,910
8,456
22,220
22,529
23,126
22,711
18,219
16,718
11,852
5,544
3,951
3,9515,54411,85216,71818,21922,71123,12622,52922,2208,4568,91018,36718,14239021314,97416,4231,9381,85912733519,14919,01518,96810,1429,92052,94543,62843,7200000
       Long term Debt Total 
0
0
0
0
0
0
0
9,008
9,029
18,376
18,622
18,777
0
0
1,775
1,775
16,326
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000016,3261,7751,7750018,77718,62218,3769,0299,0080000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,696
11,115
10,756
10,392
11,668
11,172
10,663
10,142
9,610
8,789
8,211
7,500
6,935
6,9357,5008,2118,7899,61010,14210,66311,17211,66810,39210,75611,11510,69600000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
767
808
287
174
147
44
127
84
163
0
108
213
390
17,996
18,367
8,910
8,456
22,093
22,529
14,570
14,880
10,890
10,250
5,774
0
0
005,77410,25010,89014,88014,57022,52922,0938,4568,91018,36717,996390213108016384127441471742878087670000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
145
304
304
0
0
183
0
0
0
98
0
0
0
146
0
0
0
127
0
0
0
0
0
0
0
0
0000000012700014600098000183003043041450000000
> Total Stockholder Equity
-27,259
-1,842
0
0
-50,227
-54,020
-57,278
15,235
10,137
5,870
-1,345
-7,379
3,614
-4,213
5,837
14,676
35,082
362,718
345,866
341,565
337,118
311,185
284,734
281,742
249,398
231,487
214,756
118,999
96,157
82,771
80,337
48,868
35,375
35,37548,86880,33782,77196,157118,999214,756231,487249,398281,742284,734311,185337,118341,565345,866362,71835,08214,6765,837-4,2133,614-7,379-1,3455,87010,13715,235-57,278-54,020-50,22700-1,842-27,259
   Common Stock
0
0
0
0
0
0
0
1
1
1
1
1
3
3
9
15
19
28
28
28
29
29
29
30
30
31
3
3
5
6
7
9
0
09765333130302929292828281915933111110000000
   Retained Earnings -693,225-673,100-628,854-612,630-581,208-537,317-424,751-385,839-348,715-310,038-278,229-246,071-216,119-193,170-172,417-153,631-143,684-131,953-121,161-113,087-102,577-94,677-88,279-80,614-72,762-66,351-61,425-58,113-54,266000-30,901
   Capital Surplus 
0
0
0
0
0
0
0
81,585
82,899
86,483
86,933
87,297
106,188
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
0
0
0
0
0
0
000000639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871106,18887,29786,93386,48382,89981,5850000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
-35,050
-34,604
-34,215
81,585
82,899
86,483
92,632
93,275
106,188
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
656,406
677,337
695,411
709,187
720,425
728,573
728,573720,425709,187695,411677,337656,406639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871106,18893,27592,63286,48382,89981,585-34,215-34,604-35,0500000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue30,776
Cost of Revenue-30,396
Gross Profit380380
 
Operating Income (+$)
Gross Profit380
Operating Expense-104,363
Operating Income-103,983-103,983
 
Operating Expense (+$)
Research Development24,803
Selling General Administrative51,855
Selling And Marketing Expenses0
Operating Expense104,36376,658
 
Net Interest Income (+$)
Interest Income2,101
Interest Expense-289
Other Finance Cost-3,637
Net Interest Income-1,825
 
Pretax Income (+$)
Operating Income-103,983
Net Interest Income-1,825
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-111,984-95,982
EBIT - interestExpense = -111,984
-111,984
-111,728
Interest Expense289
Earnings Before Interest and Taxes (EBIT)-111,695-111,695
Earnings Before Interest and Taxes (EBITDA)-97,469
 
After tax Income (+$)
Income Before Tax-111,984
Tax Provision-33
Net Income From Continuing Ops-112,017-112,017
Net Income-112,017
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses105,107
Total Other Income/Expenses Net-8,0011,825
 

Technical Analysis of Bionano
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionano. The general trend of Bionano is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionano's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bionano Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionano Genomics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.5181 < 4.7503 < 5.22.

The bearish price targets are: 3.6067 > 2.68.

Know someone who trades $BNGO? Share this with them.πŸ‘‡

Bionano Genomics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionano Genomics Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionano Genomics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionano Genomics Inc. The current macd is -0.05968742.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionano price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionano. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionano price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionano Genomics Inc. The current adx is 16.79.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bionano shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bionano Genomics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionano Genomics Inc. The current sar is 4.895748.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bionano Genomics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionano Genomics Inc. The current rsi is 42.55. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bionano Genomics Inc Daily Relative Strength Index (RSI) ChartBionano Genomics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionano Genomics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionano price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bionano Genomics Inc Daily Stochastic Oscillator ChartBionano Genomics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionano Genomics Inc. The current cci is -129.67027658.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bionano Genomics Inc Daily Commodity Channel Index (CCI) ChartBionano Genomics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionano Genomics Inc. The current cmo is -23.50723501.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bionano Genomics Inc Daily Chande Momentum Oscillator (CMO) ChartBionano Genomics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionano Genomics Inc. The current willr is -95.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bionano Genomics Inc Daily Williams %R ChartBionano Genomics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Bionano Genomics Inc.

Bionano Genomics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionano Genomics Inc. The current atr is 0.34652144.

Bionano Genomics Inc Daily Average True Range (ATR) ChartBionano Genomics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionano Genomics Inc. The current obv is -637,284.

Bionano Genomics Inc Daily On-Balance Volume (OBV) ChartBionano Genomics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionano Genomics Inc. The current mfi is 52.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bionano Genomics Inc Daily Money Flow Index (MFI) ChartBionano Genomics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionano Genomics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Bionano Genomics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.550
Ma 20Greater thanMa 503.928
Ma 50Greater thanMa 1003.690
Ma 100Greater thanMa 2005.917
OpenGreater thanClose3.740
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bionano with someone you think should read this too:
  • Are you bullish or bearish on Bionano? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionano? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionano Genomics Inc

I send you an email if I find something interesting about Bionano Genomics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bionano Genomics Inc.

Receive notifications about Bionano Genomics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.